Just Google key words "3E10 Yale", you may find plenty of results, including the relevant patents information.
Now 3E10 and its optimised variant PAT-DX1 are Patrys' assets under development. Patrys is a publicly traded company and must follow all the ASX listing rules including Information Disclosure. To ensure compliance, the company's ann should be the only source/form of releasing any update on the latest development of its assets. That is, it's a regulatory requirement.
Ann: PAT-DX1 Crosses Blood Brain Barrier to Reduce Tumour Size, page-88
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.229M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $130 | 32.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 29118308 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 8604045 | 13 |
View Market Depth
| Last trade - 13.17pm 19/11/2024 (20 minute delay) ? |
| PAB (ASX) Chart |